Practical tips and strategies on how to write effective partnering presentations, such as one-pagers and non-confidential decks. Suitable for for life science business development managers and executives.

With IPOs slowing and valuations compressed, out-licensing is no longer optional for small biotech—it’s strategic. This article unpacks today’s deal-making dynamics, common hurdles, and practical steps for biotech leaders preparing for early-stage out-licensing success.

A lot of life science vendors still handle cold outreach with their own teams. And sure, it can work - but often it’s slow, expensive,...

Outbound Pharma Date: 10 June 2025 We’re excited to share that Outbound Pharma has partnered with ALS International, a top recruitment...

Revenue matters, but judging business developers solely on deals closed or meetings booked misses the bigger picture. The best business developers are measured by meaningful conversations, new account growth, tailored proposals, customer acquisition, total deal value, and team contributions. Business development is a long-term investment—success is about building the future, not just closing today’s deals.

The Role of CROs and CDMOs In the life sciences industry, specialized external partners are essential for advancing therapies from...

At Outbound Pharma , we believe that behind every product and groundbreaking life science discovery is a team of passionate people...

Lead generation is more than just near-term wins. Discover how cost savings and future opportunities drive long-term ROI and sustainable

Success fee models may seem appealing for aligning interests, but they onlydrive short-term wins over quality partnerships.